摘要
癌症是心脏病后世界主要死亡原因,涉及原发部位细胞生长和可能扩散到身体其他部位的异常。肿瘤具有高度的异质性,由具有不同特征的细胞亚群组成。其中,癌症干细胞(CSC)生态位在驱动肿瘤的扩散中起着至关重要的作用,并被认为提供了治疗耐药性。CSC是一种罕见的特殊癌症细胞群,具有高致瘤能力、自我更新和分化能力。CSC不仅与高肿瘤起始活性有关,而且还与化疗耐药性、转移、上皮细胞向间充质细胞的转化和复发有关。此后,需要新的靶向CSC的治疗策略来改善长期的临床结果。文献支持海洋天然化合物具有抗氧化、抗有丝分裂、抗炎、抗生素和抗癌活性的证据。在这篇综述中,我们将深入了解选定的海洋天然产物作为具有抗癌特性的生物活性化合物来源来靶向CSC的相关性,这可能有助于新的抗癌治疗策略的发展。
关键词: 藻类、转移、静止、抗性、海绵、干性,肿瘤微环境。
Current Medicinal Chemistry
Title:Marine Natural Products as a Promising Source of Therapeutic Compounds to Target Cancer Stem Cells
Volume: 28 Issue: 22
关键词: 藻类、转移、静止、抗性、海绵、干性,肿瘤微环境。
摘要: Cancer is the world’s leading cause of death after heart diseases and involves abnormal cell growth at a primary site and the potential to spread to other parts of the body. Tumors are highly heterogeneous and consist of subgroups of cells with distinct characteristics. Of these, the cancer stem cells (CSC) niche plays a crucial role in driving the spread of the tumor and are thought to provide treatment resistance. CSC is a rare special population of cancer cells exhibiting high tumorigenic properties together with self-renewal and differentiation capability. CSC is not only linked with high tumor-initiating activity, but is also implicated in chemotherapeutic resistance, metastasis, epithelial to mesenchymal transition, and recurrence. Thereafter, novel therapeutic strategies targeting CSC are in need to improve long-term clinical outcomes. The literature supports the evidence that marine natural compounds can exhibit antioxidant, antimitotic, anti-inflammatory, antibiotic as well as anticancer activity. In this review, we will provide an insight into the relevance of selected marine natural products as a source of bioactive compounds with anti-cancer properties to target CSC, which may benefit the development of novel anti-cancer therapeutic strategies.
Export Options
About this article
Cite this article as:
Marine Natural Products as a Promising Source of Therapeutic Compounds to Target Cancer Stem Cells, Current Medicinal Chemistry 2021; 28 (22) . https://dx.doi.org/10.2174/0929867327666200320155053
DOI https://dx.doi.org/10.2174/0929867327666200320155053 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hemolysis-Associated Pulmonary Hypertension in Sickle Cell Disease: Global Disruption of the Arginine-Nitric Oxide Pathway
Current Hypertension Reviews Genistein as a Potential Anticancer Agent Against Head and Neck Squamous Cell Carcinoma
Current Topics in Medicinal Chemistry Adverse Drug Reactions in a Pulmonary Teaching Hospital: Incidence, Pattern, Seriousness, and Preventability
Current Drug Safety Editorial [Towards an Ecology of Collective Innovation: Human Variome Project (HVP), Rare Disease Consortium for Autosomal Loci (RaDiCAL) and Data-Enabled Life Sciences Alliance (DELSA)]
Current Pharmacogenomics and Personalized Medicine Potential Benefits and Limits of Psychopharmacological Therapies in Pervasive Developmental Disorders
Current Clinical Pharmacology An Emerging Antiarrhythmic Target: Late Sodium Current
Current Pharmaceutical Design Risk Factors and Potential Preventive Measures for Vascular Disease Progression in Hemodialysis Patients
Vascular Disease Prevention (Discontinued) Long Noncoding RNA OIP5-AS1 Overexpression Promotes Viability and Inhibits High Glucose-Induced Oxidative Stress of Cardiomyocytes by Targeting MicroRNA-34a/SIRT1 Axis in Diabetic Cardiomyopathy
Endocrine, Metabolic & Immune Disorders - Drug Targets Endothelial (Dys)Function in Lone Atrial Fibrillation
Current Pharmaceutical Design Editorial: Emerging Pharmacological Strategies for the Prevention of Atherosclerotic Disease Progression
Current Drug Targets - Cardiovascular & Hematological Disorders Neonatal Necrotizing Enterocolitis – Inflammation and Intestinal Immaturity
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Synthesis, Characterization and Physico-chemical Properties of New 2-(4- Arylpiperazine-1-yl)-1-(3-methylbenzofuran-2-yl)ethanoles as Potential Antihypertensive Agents
Current Organic Chemistry Hypoxia and Fetal Heart Development
Current Molecular Medicine Role of Redox Homeostasis and Inflammation in the Pathogenesis of Pulmonary Arterial Hypertension
Current Medicinal Chemistry Docking Studies for Multi-Target Drugs
Current Drug Targets New Approaches for the Treatment of Chagas Disease
Current Drug Targets Migraine Attack Treatment : A Tailor-made Suit, Not One Size Fits All
Recent Patents on CNS Drug Discovery (Discontinued) New Foods, New Consumers: Innovation in Food Product Development
Current Nutrition & Food Science Enkephalin-Fentanyl Multifunctional Opioids as Potential Neuroprotectants for Ischemic Stroke Treatment
Current Pharmaceutical Design Highest Mortality During the Last Year Before and the First Year After Start of Dialysis Treatment in Type 2 Diabetic Patients with Nephropathy
Current Diabetes Reviews